Business Type:Lab/Research institutions
Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-571-82512721
Mobile: 8615067157489
Tel: +86-571-82512721
Fax: +86-571-57153510
URL: http://www.chinazerchem.com
Province/state: Zhejiang Province
City: Hangzhou City
Street: No 317,Jingling Road,Guali Town,Xiaoshan District
MaxCard:
ProductName:hydrochlorothiazide
CAS:58-93-5
Molecular Formula:C7H8ClN3O4S2
Molecular Weight:297.73900
Physical Character:The product is white or white like crystalline powder,odorless.
Packing storage:25kg/drum
Appearance:white or almost white like crystalline powder
Loss or dry:≤0.5%
Heavy Metals:≤0.0015%
Assay:98.0%-102.0%
brief introduction:Hydrochlorothiazide (HCTZ, HCT or HZT) is a diuretic. It is usually used to treat hypertension and edema caused by fluid accumulation. Other uses include diabetes insipidus and tubular acidosis, which can also reduce hypercalciuria, thereby reducing the risk of kidney stones. In addition, the drug is often used as the first-line treatment of hypertension. Hydrochlorothiazide is an oral drug, sometimes mixed with other antihypertensive drug to make compound tablets to enhance the efficacy. Hydrochlorothiazide is classified as a thiazide drug, mainly by reducing the water retention function of the kidney. It will directly reduce blood volume, reduce the amount of blood flowing back to the heart and reduce the volume of cardiac output. Long term use of hydrochlorothiazide can reduce peripheral vascular resistance. Side effects of hydrochlorothiazide include decreased renal function, electrolyte imbalance (especially hypokalemia and, less commonly, hyponatremia), gout, hyperglycemia (hyperglycemia), and dizziness at the moment of standing up. According to the report, people who are allergic to hydrochlorothiazide often have an allergic constitution to sulfonamides, but there is not much evidence to support this argument. Although hydrochlorothiazide is still available to pregnant women, it is not the first-line drug of choice. Merck and Ciba found hydrochlorothiazide at the same time and shared the patent of this drug at that time. In January 1959, the two companies listed the drug under different trade names. Hydrochlorothiazide is listed in the list of essential drugs by the World Health Organization, which is the most important and essential drug in various medical systems. According to statistics, hydrochlorothiazide was the second most commonly used antihypertensive drug in the United States in 2008. The patent of hydrochlorothiazide has expired and belongs to the scientific name drug at present. And its price on the market is not high.
Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, we cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.
It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.